Stevanato Group S.p.A (STVN) Other Accumulated Expenses (2023 - 2026)
Stevanato Group S.p.A (STVN) posted quarterly Other Accumulated Expenses of $100.7 million for Q1 2026, up 39.08% year-over-year from $72.4 million in Q1 2025, and up 10.36% quarter-over-quarter from $91.3 million in Q4 2025.
Stevanato Group S.p.A (STVN) Other Accumulated Expenses (2023 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has reported Other Accumulated Expenses for 4 consecutive years, with $100.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Accumulated Expenses rose 39.08% year-over-year to $100.7 million; the TTM figure through Mar 2026 stood at $100.7 million (up 39.08% YoY), while the FY2025 annual figure was $91.3 million, up 27.87% from the prior year.
- Other Accumulated Expenses climbed to $100.7 million in Q1 2026 per STVN's latest filing, from $91.3 million in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $102.8 million in Q2 2025 and bottomed at $71.4 million in Q4 2024.
- Historically, Other Accumulated Expenses has averaged $87.2 million across 4 years, with a median of $90.9 million in 2025.
- Annual changes were most pronounced in 2024 — Other Accumulated Expenses slipped 12.99% — and 2026, when it soared 39.08%.
- Stevanato Group S.p.A's Other Accumulated Expenses stood at $82.0 million in 2023, then declined by 12.99% to $71.4 million in 2024, then rose by 27.87% to $91.3 million in 2025, then advanced by 10.36% to $100.7 million in 2026.
- Business Quant data shows STVN's Other Accumulated Expenses at $100.7 million in Q1 2026, $91.3 million in Q4 2025, and $90.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Stevanato Group S.p.A | 6.18 Bn | 6.07 Bn | 100.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 116.85 Mn |
| Mar 31, 2026 | 100.72 Mn |
| Dec 31, 2025 | 91.27 Mn |
| Sep 30, 2025 | 90.93 Mn |
| Jun 30, 2025 | 102.83 Mn |
| Mar 31, 2025 | 72.42 Mn |
| Dec 31, 2024 | 71.37 Mn |
| Sep 30, 2024 | 78.44 Mn |
| Jun 30, 2024 | 94.41 Mn |
| Dec 31, 2023 | 82.03 Mn |